Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Oligodendroglioma × Diffusion Tensor Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Brain Neoplasms 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Glioma 2 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neuritis 1 Neoplasm Metastasis 1 Mediastinal Neoplasms 1 Lymphedema 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 40 Radiotherapy 18 Irinotecan 11 Bevacizumab 11 Magnetic Resonance Spectroscopy 10 Carboplatin 10 Filgrastim 9 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Imatinib Mesylate 5 Etoposide 5 Carmustine 5 sargramostim 4 Peripheral Blood Stem Cell Transplantation 4 Lomustine 4 Cyclophosphamide 4 Biopsy 4 temsirolimus 3 poly ICLC 3 etoposide phosphate 3 Thalidomide 3 Surveys and Questionnaires 3 Radiation 3 Polymerase Chain Reaction 3 Immunohistochemistry 3 Gadolinium DTPA 3 Erlotinib Hydrochloride 3 Aminolevulinic Acid 3 sodium thiosulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡